Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy

Feasibility of clinical trial recruitment for cerebral amyloid angiopathy: A specialist single centre experience

(2019) Gargi Banerjee et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways

(2018) Nazira J. Albargothy et al.   ACTA NEUROPATHOLOGICA

Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy

(2018) Andreas Charidimou et al.   NEUROLOGY

Dendritic Tau in Alzheimer’s Disease

(2018) Arne Ittner et al.   NEURON

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden

(2018) Marco Duering et al.   Journal of Stroke

The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice

(2017) Gargi Banerjee et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A clinicopathological approach to the diagnosis of dementia

(2017) Fanny M. Elahi et al.   Nature Reviews Neurology

Serum neurofilament light is sensitive to active cerebral small vessel disease

(2017) Thomas Gattringer et al.   NEUROLOGY

Amyloid-PET in sporadic cerebral amyloid angiopathy

(2017) Andreas Charidimou et al.   NEUROLOGY

Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry

(2017) Nobuto Kakuda et al.   Acta Neuropathologica Communications

Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status

(2016) Laura Piccio et al.   ACTA NEUROPATHOLOGICA

Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease

(2016) Juan Domingo Gispert et al.   Alzheimers & Dementia

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

(2016) Marc Suárez‐Calvet et al.   EMBO Molecular Medicine

Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis

(2016) Dimitri Renard et al.   JOURNAL OF ALZHEIMERS DISEASE

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study

(2016) Panagiotis Fotiadis et al.   LANCET NEUROLOGY

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease

(2016) Amanda Heslegrave et al.   Molecular Neurodegeneration

β-Amyloid in CSF

(2016) Ellis S. van Etten et al.   NEUROLOGY

Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration

(2016) Henrik Zetterberg   NEURON

Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury

(2016) M. Suarez-Calvet et al.   Science Translational Medicine

Cerebral Amyloid Angiopathy-Related Atraumatic Convexal Subarachnoid Hemorrhage: An ARIA before the Tsunami

(2015) Eva Martínez-Lizana et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy

(2014) Y. D. Reijmer et al.   BRAIN

The Importance of Amyloid β Protein in Cerebrospinal Fluid when You Recognize Convexal Subarachnoid Hemorrhage

(2014) Ryota Tamura et al.   EUROPEAN NEUROLOGY

Outcome markers for clinical trials in cerebral amyloid angiopathy

(2014) Steven M Greenberg et al.   LANCET NEUROLOGY

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

(2014) G. Kleinberger et al.   Science Translational Medicine

Truncated and modified amyloid-beta species

(2014) Markus P Kummer et al.   Alzheimers Research & Therapy

Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy

(2013) S. Peca et al.   NEUROLOGY

Review: Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy

(2013) R. O. Carare et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria

(2012) Dimitri Renard et al.   JOURNAL OF NEUROLOGY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy

(2010) J. Linn et al.   NEUROLOGY

Cerebrospinal fluid amyloid β40is decreased in cerebral amyloid angiopathy

(2009) Marcel M. Verbeek et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study

(2009) M. Jonsson et al.   EUROPEAN JOURNAL OF NEUROLOGY